Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2021 08:00 ET | Source: Lanier Biotherapeutics

Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics

BOGART, Ga., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Lanier Biotherapeutics Inc., (“Lanier” or the “Company”), a developer of first-in-class antibodies targeting retina, dermatology, and Type 2...